
	Will Waddill joined Calithera BioSciences as Senior Vice President,&nbsp; Chief Financial Officer, in April 2014. He began his career 30 years ago in commercial banking and public accounting and has been in the biotechnology industry for over 20 years. Prior to joining Calithera, Mr. Waddill was Senior Vice President, CFO, at OncoMed Pharmaceuticals from 2007 to 2014, where he was responsible for all corporate financial matters, most notably the successfully completed $94 million Initial Public Offering in July 2013, private equity financing of $126 million in December 2008, and three collaborations valued at $6.1 billion.&nbsp; Prior to OncoMed, Will was Senior Vice President, CFO, at Ilypsa, where he was the finance lead for the $420 million acquisition by Amgen in 2007.&nbsp; Before joining Ilypsa, Will served as the founder and principal at Square One Finance, a financial consulting business, managing the finances of 33 start-up biotechnology companies, including eight that became public and six that have been acquired.&nbsp; Mr. Waddill serves on the board of the Association of Bioscience Financial Officers and Chaired their 2014 National Conference, and was formerly the Chairman of the Biotechnology Industry Organization (BIO) BIO Business Solutions Advisory Board and Finance and Tax Committee.&nbsp; He received a BS in accounting from the University of Illinois, Chicago, and certification as a public accountant (inactive) after working at PriceWaterhouseCoopers and Deloitte in Boston.
